Serotonin Signaling Through the 5-HT1B Receptor and NADPH Oxidase 1 in Pulmonary Arterial Hypertension

Arterioscler Thromb Vasc Biol. 2017 Jul;37(7):1361-1370. doi: 10.1161/ATVBAHA.116.308929. Epub 2017 May 4.

Abstract

Objective: Serotonin can induce human pulmonary artery smooth muscle cell (hPASMC) proliferation through reactive oxygen species (ROS), influencing the development of pulmonary arterial hypertension (PAH). We hypothesize that in PASMCs, serotonin induces oxidative stress through NADPH-oxidase-derived ROS generation and reduced Nrf-2 (nuclear factor [erythroid-derived 2]-like 2) antioxidant systems, promoting vascular injury.

Approach and results: HPASMCs from controls and PAH patients, and PASMCs from Nox1-/- mice, were stimulated with serotonin in the absence/presence of inhibitors of Src kinase, the 5-HT1B receptor, and NADPH oxidase 1 (Nox1). Markers of fibrosis were also determined. The pathophysiological significance of our findings was examined in vivo in serotonin transporter overexpressing female mice, a model of pulmonary hypertension. We confirmed thatserotonin increased superoxide and hydrogen peroxide production in these cells. For the first time, we show that serotonin increased oxidized protein tyrosine phosphatases and hyperoxidized peroxiredoxin and decreased Nrf-2 and catalase activity in hPASMCs. ROS generation was exaggerated and dependent on cellular Src-related kinase, 5-HT1B receptor, and the serotonin transporter in human pulmonary artery smooth muscle cells from PAH subjects. Proliferation and extracellular matrix remodeling were exaggerated in human pulmonary artery smooth muscle cells from PAH subjects and dependent on 5-HT1B receptor signaling and Nox1, confirmed in PASMCs from Nox1-/- mice. In serotonin transporter overexpressing mice, SB216641, a 5-HT1B receptor antagonist, prevented development of pulmonary hypertension in a ROS-dependent manner.

Conclusions: Serotonin can induce cellular Src-related kinase-regulated Nox1-induced ROS and Nrf-2 dysregulation, contributing to increased post-translational oxidative modification of proteins and activation of redox-sensitive signaling pathways in hPASMCs, associated with mitogenic responses. 5-HT1B receptors contribute to experimental pulmonary hypertension by inducing lung ROS production. Our results suggest that 5-HT1B receptor-dependent cellular Src-related kinase-Nox1-pathways contribute to vascular remodeling in PAH.

Keywords: NADPH oxidase; hypertension, pulmonary; models, animal; receptor, serotonin, 5-HT1B; serotonin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Animals
  • Antihypertensive Agents / pharmacology
  • Arterial Pressure* / drug effects
  • Case-Control Studies
  • Cell Proliferation
  • Cells, Cultured
  • Disease Models, Animal
  • Enzyme Inhibitors / pharmacology
  • Extracellular Matrix / metabolism
  • Female
  • Genetic Predisposition to Disease
  • Humans
  • Hypertension, Pulmonary / enzymology*
  • Hypertension, Pulmonary / pathology
  • Hypertension, Pulmonary / physiopathology
  • Hypertension, Pulmonary / prevention & control
  • Hypoxia / complications
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Mice, Transgenic
  • Middle Aged
  • NADH, NADPH Oxidoreductases / antagonists & inhibitors
  • NADH, NADPH Oxidoreductases / deficiency
  • NADH, NADPH Oxidoreductases / genetics
  • NADH, NADPH Oxidoreductases / metabolism*
  • NADPH Oxidase 1
  • NADPH Oxidases / antagonists & inhibitors
  • NADPH Oxidases / metabolism*
  • NF-E2-Related Factor 2 / metabolism
  • Oxidative Stress
  • Peroxiredoxins / metabolism
  • Phenotype
  • Protein Carbonylation
  • Pulmonary Artery / drug effects
  • Pulmonary Artery / enzymology*
  • Pulmonary Artery / pathology
  • Pulmonary Artery / physiopathology
  • Reactive Oxygen Species / metabolism
  • Receptor, Serotonin, 5-HT1B / drug effects
  • Receptor, Serotonin, 5-HT1B / metabolism*
  • Serotonin / metabolism*
  • Serotonin 5-HT1 Receptor Antagonists / pharmacology
  • Serotonin Plasma Membrane Transport Proteins / genetics
  • Serotonin Plasma Membrane Transport Proteins / metabolism
  • Signal Transduction
  • Time Factors
  • Vascular Remodeling
  • src-Family Kinases / antagonists & inhibitors
  • src-Family Kinases / metabolism

Substances

  • Antihypertensive Agents
  • Enzyme Inhibitors
  • HTR1B protein, human
  • HTR1B protein, mouse
  • NF-E2-Related Factor 2
  • NFE2L2 protein, human
  • Nfe2l2 protein, mouse
  • Reactive Oxygen Species
  • Receptor, Serotonin, 5-HT1B
  • Serotonin 5-HT1 Receptor Antagonists
  • Serotonin Plasma Membrane Transport Proteins
  • Serotonin
  • Peroxiredoxins
  • NADH, NADPH Oxidoreductases
  • NADPH Oxidase 1
  • NADPH Oxidases
  • NOX1 protein, human
  • NOX1 protein, mouse
  • src-Family Kinases